secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001213900-23-065088
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma regains Nasdaq minimum bid price compliance, delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq notification on Aug 8, 2023 confirming compliance with Rule 5550(a)(2).
- Closing bid price was $1.00 or above for 10 consecutive days (July 25 – Aug 7, 2023).
- Previously received deficiency letter on Aug 19, 2022; compliance deadline extended to Aug 14, 2023.
- Matter now closed; no further action required by Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023065088/0001213900-23-065088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023065088/ea183183-8ka_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-065088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer